CVE-2025-3322 Details
Description
An improper neutralization of inputs used in expression language allows remote code execution with the highest privileges on the server.
A vulnerability allowing remote code execution with elevated privileges on the server has been identified in B. Braun products. This issue arises from improper handling of inputs in the expression language, which can be exploited to execute arbitrary code.
Metrics
CVSS 4.0 Severity and Vector Strings:
CVSS 3.x Severity and Vector Strings:
No data available for CVSS Version 2.0 on this CVE.
Volerion
Assessed Jun 6, 2025CISA-ADP
Assessed Jun 6, 2025References to Advisories, Solutions, and Tools
By selecting these links, you will be leaving this site. These are references gathered from the official CVE record and are not endorsed by Volerion.
| URL | Source(s) | Tag(s) |
|---|---|---|
| https://www.bbraun.com/productsecurity | [email protected] | Vendor |
Weakness Enumeration
| CWE-ID | CWE Name | Source |
|---|---|---|
| CWE-917 | Improper Neutralization of Special Elements used in an Expression Language Statement ('Expression Language Injection') | [email protected] |
Affected Products
| Product | Versions |
|---|---|
| B. Braun OnlineSuite | All versions |
CPE
Remediation
| |
Change History
3 change records found show changes
| Date | Action | Recorded By |
|---|---|---|
| Jun 17, 2026 | CVE Modified | [email protected] |
| Jun 17, 2026 | CVE Modified | CISA-ADP |
| Jun 6, 2025 | New CVE Received | [email protected] |
Volerion